Stanford University


Showing 14,301-14,310 of 34,423 Results

  • Peter Kao

    Peter Kao

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly InterestsOur research program has several active projects:
    1.) Pulmonary Vascular Disease – Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
    2.) Lung inflammation and regeneration (stem cells)
    3.) Lung surfactant rheology and oxidative stress
    4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms

  • Pankaj Kapahi

    Pankaj Kapahi

    Professor (Research) of Medicine (Endocrinology)

    BioPankaj Kapahi is a Professor and aging researcher whose laboratory seeks to understand why organisms age and why the rate and consequences of aging differ so dramatically between individuals, sexes, and species. The lab approaches aging through the lens of evolution, asking how pathways that evolved to optimize growth, reproduction, and survival early in life can shape health and disease later in life.

    A major focus of the laboratory is the interaction between nutrition, metabolism, reproduction, and aging. The lab has helped define how nutrient-sensing pathways, including TOR, dietary restriction, circadian biology, and metabolic adaptation regulate lifespan and age-related disease. More recently, this work has expanded to reproductive aging and the Reproductive Resilience Hypothesis, the idea that evolutionary pressures linking reproductive success to prolonged survival, repeated reproduction, and caregiving may have selected for biological programs that simultaneously support reproduction and somatic resilience.

    Using comparative and experimental approaches across flies, worms, mice, and humans, the lab studies how these evolutionarily conserved programs influence brain aging, neurodegeneration, metabolic disease, reproductive aging, cell senescence, and resilience. The broader philosophy of the laboratory is that aging is best understood not as an isolated biological program, but as an emergent consequence of the evolutionary trade-offs among reproduction, nutrition, growth, maintenance, and survival.

  • Zerina Kapetanovic

    Zerina Kapetanovic

    Assistant Professor of Electrical Engineering and, by courtesy, of Computer Science and of Geophysics

    BioZerina Kapetanovic is an Assistant Professor in the Department of Electrical Engineering at Stanford University working in the area of low-power wireless communication, sensing, and Internet of Things (IoT) systems. Prior to starting at Stanford, Kapetanovic was a postdoctoral researcher at Microsoft Research in the Networking Research Group and Research for Industry Group.

    Kapetanovic's research has been recognized by the Yang Research Award, the Distinguished Dissertation Award from the University of Washington. She also received the Microsoft Research Distinguished Dissertation Grant and was selected to attend the 2020 UC Berkeley Rising Stars in EECS Workshop. Kapetanovic completed her PhD in Electrical Engineering from the University of Washington in 2022.

  • Michael S. Kapiloff, MD, PhD

    Michael S. Kapiloff, MD, PhD

    Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.

    URL to NCBI listing of all published works:
    http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending

    For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html